 |
|
|
| |
Perceived Implementation Barriers Decrease During Initial Stages of an Implementation Science Hybrid III Study (CUSTOMIZE) of Cabotegravir and Rilpivirine Long-Acting (CAB + RPV LA) in
US Healthcare Settings: Healthcare Team Perspective
|
| |
| |
IAC 2020 Virtual July 6-10
Reported by Jules Levin
Maggie Czarnogorski,1 Cindy Garris,1 Paul Wannamaker,1 Ronald D’Amico,1 Deanna Merrill,1 Colleen A. McHorney,2 Larissa Stassek,2 Sonal Mansukhani,2 Jason Flamm,3 Blair Thedinger,4 Paul Benson,5 Michael Wolfeiler,6 Gary Sinclair,7 William Spreen1
1ViiV Healthcare, Research Triangle Park, NC, USA; 2Evidera, Bethesda, MD, USA; 3Kaiser Permanente Sacramento, Sacramento, CA, USA; 4Kansas City Free Health Clinic, Kansas City, MO, USA; 5Be Well Medical Center, Berkley, MI, USA; 6AIDS Healthcare Foundation, Los Angeles, CA, USA; 7PrismHealth North Texas, Dallas, TX, USA
|
| |
|
|
|
|
|
